Bicara Therapeutics Inc. Common Stock

BCAX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$7.93-13.14%

2026-11-02

Financials

Valuation Metrics

Bicara Therapeutics Inc. Common Stock's Market Cap is $521M. At end of 2025 it was $928M. Ranked #2668 of 3,118 in US market (top 86%), #1149 of 1,474 on NASDAQ (top 78%), #207 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 78%) by Market Cap.

Investment Metrics(as of 2026-11-02)

Metric	Value	Rank
Size
Market Cap	$521M	US#2,668/3,118 Sec#207/265
Revenue	$0.00	US#2,858/3,118 Sec#193/265
Net Income	$-185M	US—/3,118 Sec—/265
Total Assets	$512M	US#2,750/3,118 Sec#162/265
Net Assets	$469M	US#2,263/3,118 Sec#113/265
Value
P/B	1.11x	US#704/3,118 Sec#31/265
FCF Yield	-25.96%	US—/3,118 Sec—/265
Profitability
ROE	-39.54%	US#2,620/3,118 Sec#137/265
ROA	-36.19%	US#2,919/3,118 Sec#177/265
Financial Health
Debt Ratio	9.27%	US#99/3,118 Sec#48/265
Total Debt	$1M	US#2,961/3,118 Sec#239/265
FCF	$-135M	US#2,696/3,118 Sec#170/265
Cash	$97M	US#2,253/3,118 Sec#178/265
Current Ratio	11.59x	US#208/3,118 Sec#65/265
Performance
1Y Return	-51.20%	US#2,807/3,118 Sec#229/265
1M Return	-55.02%	US#3,101/3,118 Sec#263/265
From 52W High	-74.41%	US#2,974/3,118 Sec#239/265
1Y MDD	-73.91%	US#2,928/3,118 Sec#235/265
Trading
Volume	2,474,240 shares	US#523/3,118 Sec#38/265
Trading Value	$21M	US#1,538/3,118 Sec#107/265
Per Share
EPS	$-2.82	US—/3,118 Sec—/265
BPS	$7.13	US#2,070/3,118 Sec#96/265